Sotera Health price target raised to $20 from $19 at Barclays

Barclays raised the firm’s price target on Sotera Health (SHC) to $20 from $19 and keeps an Overweight rating on the shares. The company reported a “solid” quarter as the business is operating at a normal level following the last year of supply chain issues, the analyst tells investors in a research note.